BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
토요일, 9월 26

Arbutus Biopharma Corp

ABUSNASDAQ
Trade with Public
Trade with Public
$4.85
-0.03-0.61%
가까이에: Sep 25, 5:00 PM EST
$4.86
0.01010.21%
시간외: 7:57 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Arbutus Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Arbutus Biopharma (ABUS).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

1S.Buy
3Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$6Upside to Avg. PT+13.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Nov 14, 2025Chardan CapitalKeay NakaeMaintainedBuy$5
Aug 11, 2025Chardan CapitalKeay NakaeMaintainedBuy$5
More with Benzinga EdgeGet Access

Analyst Ratings News

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor concerns and clearing legal uncertainty.
Vandana Singh

PRO
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Arbutus Biopharma, Maintains $5 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

Walmart To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved